These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10580424)

  • 1. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells.
    Zhou J; Wang X; Pineyro MA; Egan JM
    Diabetes; 1999 Dec; 48(12):2358-66. PubMed ID: 10580424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells.
    Bai L; Meredith G; Tuch BE
    J Endocrinol; 2005 Aug; 186(2):343-52. PubMed ID: 16079260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.
    Bulotta A; Hui H; Anastasi E; Bertolotto C; Boros LG; Di Mario U; Perfetti R
    J Mol Endocrinol; 2002 Dec; 29(3):347-60. PubMed ID: 12459036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.
    Perry T; Lahiri DK; Chen D; Zhou J; Shaw KT; Egan JM; Greig NH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):958-66. PubMed ID: 11861804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional maturation of fetal porcine beta-cells by glucagon-like peptide 1 and cholecystokinin.
    Hardikar AA; Wang XY; Williams LJ; Kwok J; Wong R; Yao M; Tuch BE
    Endocrinology; 2002 Sep; 143(9):3505-14. PubMed ID: 12193564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
    Skoglund G; Hussain MA; Holz GG
    Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells.
    Zhou J; Montrose-Rafizadeh C; Janczewski AM; Pineyro MA; Sollott SJ; Wang Y; Egan JM
    J Cell Physiol; 1999 Dec; 181(3):470-8. PubMed ID: 10528233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells.
    Hui H; Wright C; Perfetti R
    Diabetes; 2001 Apr; 50(4):785-96. PubMed ID: 11289043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1.
    Idris I; Patiag D; Gray S; Donnelly R
    Biochem Pharmacol; 2002 Mar; 63(5):993-6. PubMed ID: 11911852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
    Abraham EJ; Leech CA; Lin JC; Zulewski H; Habener JF
    Endocrinology; 2002 Aug; 143(8):3152-61. PubMed ID: 12130581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
    Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
    Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
    Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
    J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
    Perry T; Lahiri DK; Sambamurti K; Chen D; Mattson MP; Egan JM; Greig NH
    J Neurosci Res; 2003 Jun; 72(5):603-12. PubMed ID: 12749025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin hormones and insulin sensitivity.
    Hansen PA; Corbett JA
    Trends Endocrinol Metab; 2005; 16(4):135-6. PubMed ID: 15860408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of glucagon-like peptide-1 and transforming growth factor-beta signaling in insulin-positive differentiation of AR42J cells.
    Yew KH; Prasadan KL; Preuett BL; Hembree MJ; McFall CR; Benjes CL; Crowley AR; Sharp SL; Li Z; Tulachan SS; Mehta SS; Gittes GK
    Diabetes; 2004 Nov; 53(11):2824-35. PubMed ID: 15504962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.